Skip to main content

Advertisement

Log in

Synthesis and Antiviral Properties of Ethyl(3-ethyladamant-1-yl)carbamate

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The new adamantine derivative ethyl(3-ethyladamant-1-yl)carbamate was found to have high antiviral activity against herpes simplex virus and vaccinia viruses, as well as adenovirus (EC50 = 0.62, 5.15, and 48.5 μg/ml respectively). Activity against the herpesvirus was demonstrated in experiments in various cell cultures using different virus strains, including a variant resistant to acycloguanosine (ACG). Simultaneous application of ethyl(3-ethyladamant-1-yl)carbamate and ACG increased the inhibition of herpesvirus reproduction in cell cultures and decreased the mortality of laboratory animals with experimental herpesvirus neuroinfection as compared with the use of each substance alone. 3-Ethyladamant-1-yl)carbamate was a low-toxicity compound, did not inhibit DNAsynthesis in uninfected cell cultures, and its acute intragastric LD50 for white mice was 1831.8 mg/kg.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. V. A. Isakov, S. A. Sel’kov, L. K. Moshetova, and G. M. Chernakova, Current Treatment of Herpesvirus Infections: Handbook for Physicians [in Russian], Meditsina, St. Petersburg (2004), pp. 5 – 11.

    Google Scholar 

  2. G. A. Galegov, Consilium Medicum, 4, No. 5, 240 – 243 (2002).

    Google Scholar 

  3. M. J. Levin, T. H. Bacon, J. J. Leary, Clin. Infect. Dis., 39(5), 248 – 257 (2004).

    Article  Google Scholar 

  4. E. Frobert, J.-C. Cortay, T. Ooka, et al., Antiviral Res., 79(1), 28 – 36 (2008).

    Article  CAS  PubMed  Google Scholar 

  5. E. I. Boreko, L. V. Rubanik, O. V. Savinova, et al., Med. Panorama, No. 1, 30 – 34 (2014).

  6. G. Fytas, P. Marakos, N. Kolocouris, et al., Farmaco, 49(10), 641 – 647 (1994).

    CAS  PubMed  Google Scholar 

  7. C. Fleck, E. Franzmann, D. Claes, et al., Synthesis, 45(11), 1452 – 1461 (2013).

    Article  CAS  Google Scholar 

  8. M. A. El-Sherbeny, K. M. Youssef and M. A. Mahran, Scientia Pharmaceutica, 71(3), 195 – 209 (2003).

    CAS  Google Scholar 

  9. V. A. Ignatenko, P. Zhang and R. Viswanathan, Tetrahedron Lett., 52(12), 1269 – 1272 (2011).

    Article  CAS  Google Scholar 

  10. Yu. N. Klimochkin and I. K. Moiseev, Zh. Organ. Khimii, 27(4), 1795 – 1796 (1991).

    CAS  Google Scholar 

  11. Yu. N. Klimochkin, E. I. Bagrii, T. N. Dolgopolova, I. K. Moiseev, Izv. Akad Nauk. SSSR. Ser. Khim., No. 4, 878 – 880 (1988).

  12. Yu. N. Klimochkin, I. K. Moiseev, E. I. Boreko, et al., Khim-Farm. Zh., 23(4), 418 – 421 (1989); Pharm. Chem. J., 23(4), 304 – 307 (1989).

  13. I. K. Moiseev, E. I. Bagrii, Yu. N. Klimochkin, et al., Izv. Akad. Nauk. SSSR. Ser. Khim., No. 9, 2141 – 2143, No. 1985.

  14. K. P. Fung, Comput. Biol. Med., 19(2), 131 – 135 (1989).

    Article  CAS  PubMed  Google Scholar 

  15. E. De Clercq, J. Descamps, G. Verhelst, et al., J. Inf. Dis., 141(5), 563 – 574 (1980).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu. N. Klimochkin.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 51, No. 1, pp. 15 – 19, January, 2017.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klimochkin, Y.N., Moiseev, I.K., Leonova, M.V. et al. Synthesis and Antiviral Properties of Ethyl(3-ethyladamant-1-yl)carbamate. Pharm Chem J 51, 13–17 (2017). https://doi.org/10.1007/s11094-017-1548-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-017-1548-9

Keywords

Navigation